Fumaric Acid

Fumaric Acid

SCHEMBL6298022

C[C@H]1CN(c2cc(Cl)cc3ccoc23)CCN1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 1/20 0.44
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
XIAP P98170 6/20 0.37
BIRC2 Q13490 6/20 0.37
HRH4 Q9H3N8 2/20 0.35
BCL2A1 Q16548 2/20 0.35
HTR6 P50406 2/20 0.34
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6298023 1.00 HTR2C (0.44) HTR2CALDH1A1LMNAXIAPBIRC2
Fumaric Acid SCHEMBL6300513 0.82 HTR6 (0.34) XIAPBIRC2HTR6
Fumaric Acid SCHEMBL6300516 0.82 HTR6 (0.34) XIAPBIRC2HTR6
Fumaric Acid SCHEMBL6299233 0.79 HTR2C (0.53) HTR2CALDH1A1LMNAXIAPBIRC2
Fumaric Acid SCHEMBL6299232 0.79 HTR2C (0.53) HTR2CALDH1A1LMNAXIAPBIRC2
Fumaric Acid SCHEMBL6304470 0.78 HTR2C (0.35) HTR2CHRH4
Fumaric Acid SCHEMBL6299353 0.78 HTR2C (0.35) HTR2CHRH4
Fumaric Acid SCHEMBL6304471 0.78 HTR2C (0.35) HTR2CHRH4
Fumaric Acid SCHEMBL6299355 0.78 HTR2C (0.35) HTR2CHRH4
Fumaric Acid SCHEMBL6299334 0.76 PRKCQ (0.36) HTR2CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed